As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A milestone review examining 1.4 million patients worldwide found that those who do not see the same doctor regularly are ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment ... impairment and dementia, researchers and clinicians ... Ditch TV and Read a Book: Research Delivers Best Moves to Reduce ...

For many nursing home residents, a trip to the hospital can be a jarring experience — one that leaves them confused and ...

Our Top PicksBest rechargeableJabra EnhanceBest basic optionsMDHearingEasiest insertionEargoHearing loss may affect cognition ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with dementia with Lewy bodies, or DLB, failed to meet its main goals.

Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. That virus has not yet shown the capacity for human-to ...

In November, 499,068 people in England received a dementia diagnosis – a jump of 19,416 in a year. A timely diagnosis can mean patients and ... support and treatment. It can also help people ...

Christmas brings families together, often highlighting early signs of dementia in loved ... are crucial for ensuring patients receive necessary care, support, and treatment to manage symptoms ...

An early dementia diagnosis can help with treatment and planning for the futureCredit ... If you notice any symptoms in loved ones the best thing to do is to speak with them honestly and openly ...